Xilio Therapeutics
XLO
#9721
Rank
โ‚ฌ31.72 M
Marketcap
0,61ย โ‚ฌ
Share price
-0.42%
Change (1 day)
-54.85%
Change (1 year)

Operating Margin for Xilio Therapeutics (XLO)

Operating Margin at the end of 2024: -918.05%

According to Xilio Therapeutics's latest financial reports and stock price the company's current Operating Margin is -918.04%. At the end of 2024 the company had an Operating Margin of -918.05%.

Operating Margin history for Xilio Therapeutics from 2024 to 2024

Operating Margin at the end of each year

Year Operating Margin Change
2024-918.05%

What is a company's Operating Margin?

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.